Elworthy; Todd Richard
Patent Applications and Registrations
Patent applications and USPTO patent grants for Elworthy; Todd Richard.The latest application filed is for "heterocyclic antiviral compounds".
- Elworthy; Todd Richard - Los Gatos CA
- Elworthy; Todd Richard - Los Altos CA
- Elworthy; Todd Richard - Palo Alto CA
| Patent | Date |
|---|---|
| Heterocyclic antiviral compounds Grant 8,293,778 - Dunn , et al. October 23, 2 | 2012-10-23 |
| Salicylamide derivatives as nicotinic alpha 7 modulators Grant 8,198,332 - Elworthy June 12, 2 | 2012-06-12 |
| Pyrrolopyrazine kinase inhibitors Grant 8,119,636 - DuBois , et al. February 21, 2 | 2012-02-21 |
| Pyrrolopyrazine kinase inhibitors Grant 8,008,298 - Bamberg , et al. August 30, 2 | 2011-08-30 |
| Heterocyclic Antiviral Compounds App 20110207688 - Dunn; James Patrick ; et al. | 2011-08-25 |
| Tetrazole-substituted aryl amide derivatives and uses thereof Grant 7,981,914 - Du Bois , et al. July 19, 2 | 2011-07-19 |
| Non-nucleoside reverse transcriptase inhibitors Grant 7,947,709 - Elworthy , et al. May 24, 2 | 2011-05-24 |
| Pyrrolopyrazine kinase inhibitors Grant 7,939,531 - Bamberg , et al. May 10, 2 | 2011-05-10 |
| Pyrrolopyrazine kinase inhibitors Grant 7,902,197 - Elworthy , et al. March 8, 2 | 2011-03-08 |
| Pyrrolopyrazine kinase inhibitors App 20100267666 - Bamberg; Joe Timothy ; et al. | 2010-10-21 |
| Heterocyclic antiviral compounds Grant 7,666,891 - Dunn , et al. February 23, 2 | 2010-02-23 |
| Salicylamide derivatives as nicotinic alpha 7 modulators App 20100041763 - Elworthy; Todd Richard | 2010-02-18 |
| Pyrrolopyrazine kinase inhibitors App 20090215750 - Bamberg; Joe Timothy ; et al. | 2009-08-27 |
| Pyrrolopyrazine kinase inhibitors App 20090215788 - Elworthy; Todd Richard ; et al. | 2009-08-27 |
| Pyrrolopyrazine kinase inhibitors App 20090215785 - DuBois; Daisy Joe ; et al. | 2009-08-27 |
| Tetrazole-substituted aryl amide derivatives and uses thereof App 20090093523 - Du Bois; Daisy Joe ; et al. | 2009-04-09 |
| Non-Nucleoside reverse transcriptase inhibitors App 20090012034 - Elworthy; Todd Richard ; et al. | 2009-01-08 |
| 2-Piperidone derivatives as prostaglandin antagonists App 20080058375 - Elworthy; Todd Richard | 2008-03-06 |
| Non-nucleoside reverse transcriptase inhibitors Grant 7,288,542 - Dunn , et al. October 30, 2 | 2007-10-30 |
| 2-Piperidone derivatives as prostaglandin agonists Grant 7,271,183 - Elworthy September 18, 2 | 2007-09-18 |
| Heterocyclic antiviral compounds App 20060025462 - Dunn; James Patrick ; et al. | 2006-02-02 |
| Non-nucleoside reverse transcriptase inhibitors App 20050215554 - Dunn, James Patrick ; et al. | 2005-09-29 |
| 8-aza-11-deoxy prostaglandin analogues Grant 6,900,336 - Elworthy , et al. May 31, 2 | 2005-05-31 |
| 2-pyrrolidone derivatives as prostanoid agonists Grant 6,849,657 - Elworthy , et al. February 1, 2 | 2005-02-01 |
| 2-Piperidone derivatives as prostaglandin agonists App 20040142969 - Elworthy, Todd Richard | 2004-07-22 |
| 8-Aza-11-deoxy prostaglandin analogues App 20030120079 - Elworthy, Todd Richard ; et al. | 2003-06-26 |
| 2-pyrrolidone derivatives as prostanoid agonists App 20030064964 - Elworthy, Todd Richard ; et al. | 2003-04-03 |
| [3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy]-pyridine, pyrimidine and benzene derivatives as .alpha..sub.1 -adrenoceptor antagonists Grant 5,688,795 - Pfister , et al. November 18, 1 | 1997-11-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 